Navigation Links
Flu Vaccine Can Be Used To Treat Lung Cancer

A group of researchers at Vienna University have said they are trying to develop an existing influenza vaccine so that it will be effective against lung cancer//.

Experiments with mice have already yielded first successes, but much more research was still needed before the new therapy could be used on humans, said a university statement Tuesday.

"In fact it's a paradox," said research scientist Christian Kittel at the Institute of Applied Microbiology.

"Influenza viruses normally cause flu in human beings, and thereby an extremely dangerous illness, which for some patients even ends fatally."

"But now we want to treat an even more dangerous illness, lung cancer, with them," he said.

The researchers explained that the human immune system usually stands no chance against cancer, as it cannot distinguish between healthy and cancerous cells.

But now they had succeeded in altering an existing influenza vaccine so that it acted on the immune system like a sparkplug, giving it a kick-start. Then the system becomes so highly sensitised that it could recognise cancer cells and destroy them, scientists explained.

The existing vaccine was attenuated - a toned-down influenza virus, which could not cause the disease itself but still infected the lungs.

The researchers had developed the virus further so that it now also contained the building plan for production of the immune "messenger" Interleukin-2. This material had already previously been gene-technically manufactured and tested.

"But it was administered to the patients systematically (by infection) and in high dosages. That did in fact have an effect, but also strong side-effects."

This problem would be avoided by using the influenza viruses as conveyances. The virus-infected cells of the lungs would then produce and release the Interleukin-2 just where it was needed.

The substance would activa te the pulmonary immune system to such an extent that it could recognise and fight the cancer.

--DPA
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... 09, 2016 , ... Traumatic Brian Injury is often in ... one of many possible sources: sports, car accidents, falls, work accidents, combat and ... Rehab Solutions for the Complexities of Concussions is designed for physical and ...
(Date:2/9/2016)... ... 09, 2016 , ... Center for Autism and Related Disorders ... spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid is covering autism treatment in ... key to providing effective treatment for individuals with ASD. Now, over 1,800 low-income ...
(Date:2/9/2016)... ... February 09, 2016 , ... URise Products announces today ... device, the StandUp Walker. Made entirely in the USA, the StandUp Walker is ... , StandUp Walker’s novel patent-pending design offers 2-in-1 benefits of a stand-assist ...
(Date:2/9/2016)... (PRWEB) , ... February 09, ... ... print and e-book publishing software, in partnership with Snowfall4pod Digital, creators of ... a comprehensive book publishing, content management, global distribution and print-on-demand network. , ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul McElwee, a ... they noticed their furnace not producing any heat. Shortly after entering the home, Paul ... exchanger was leaking dangerous levels of carbon monoxide into the home, at 2,000 parts ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016 --> ... Therapeutics and Companion Diagnostic Market to 2019 - ... Environment" research report indicates that the core personalized ... by 2020 growing at a CAGR of 8.74%. ... and targeted therapeutics and is dominated by oncology, ...
(Date:2/10/2016)... February 10, 2016 Demonstrates ... 1 receptor selectivity   1 ... which has entered clinical development as a new ... and schizophrenia.   --> 1 ... has entered clinical development as a new treatment ...
(Date:2/9/2016)... Inc. (NASDAQ: MSON ), an international surgical ... therapeutic ultrasonic products for spine surgery, skull-based surgery, ... other surgical applications, today announced financial results for ... fiscal year 2016 ended December 31, 2015. ... Highlights for the second quarter and first half ...
Breaking Medicine Technology: